BIM-44058

BIM-44058 from HG Wellness Peptides is intended for researchers focused on gut hormone biology, mucosal biology, and tissue-response mechanisms. As a GLP-2-pathway agonist, it is suited to in vitro or preclinical models investigating epithelial cellular processes, nutrient-transport mechanisms, and intestinal barrier signaling and function.
The peptide is manufactured in U.S.-based GMP facilities via solid-phase synthesis, then purified and characterized with third-party HPLC and MS testing. Each lot is assigned a distinct batch number, with a matching Certificate of Analysis that details purity data and analytical conditions, simplifying method documentation and reproducibility across studies.
Supplied as a lyophilized powder for improved stability, BIM-44058 integrates into gastrointestinal research workflows where traceability and analytical clarity are essential.
BIM-44058 is provided exclusively for Research Use Only and is not intended for human or veterinary administration.
Disclaimer
All products offered by HG Wellness Peptides are strictly intended for laboratory, scientific, and research purposes only. They are NOT for human consumption, clinical use, veterinary application, diagnostic procedures, or direct administration of any kind.
None of the statements on this website have been evaluated or approved by the U.S. Food and Drug Administration (FDA). These products are not medical devices, supplements, or drugs, and are not intended to diagnose, treat, cure, or prevent any disease, condition, or physical ailment.
By purchasing from this website, the buyer acknowledges and agrees that they are at least 21 years of age and are fully qualified, trained, and equipped to handle research chemicals in accordance with applicable laws, health, and safety protocols. HG Wellness Peptides assumes no liability for any direct, indirect, or consequential damages resulting from improper handling, misuse, or unauthorized application of these products.
Reach Out Anytime
Send questions about peptides, orders, or documentation, and our team responds promptly with clear, evidence-based guidance.
